We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+1.8%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$247B
AUM Growth
-$6.76B
(-2.7%)
Cap. Flow
-$7.92B
Cap. Flow
% of AUM
-3.2%
Top 10 Holdings %
Top 10 Hldgs %
17.52%
Holding
3,301
New
48
Increased
1,481
Reduced
1,530
Closed
86
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity National Information Services
FIS
|
+$508M |
| 2 |
L3Harris
LHX
|
+$420M |
| 3 |
Salesforce
CRM
|
+$251M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$225M |
| 5 |
Texas Instruments
TXN
|
+$185M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.13B |
| 2 |
Microsoft
MSFT
|
+$408M |
| 3 |
PayPal
PYPL
|
+$367M |
| 4 |
Qualcomm
QCOM
|
+$306M |
| 5 |
WP
Worldpay, Inc.
WP
|
+$281M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.75% |
| 2 | Financials | 14.53% |
| 3 | Healthcare | 12.29% |
| 4 | Consumer Discretionary | 10.49% |
| 5 | Industrials | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
Pulse Biosciences
PLSE
$2.94B
| $627K | ﹤0.01% |
40,610
-2,164
| -5% | -$28.1K |
|
2877
Amalgamated Financial
AMAL
$1.49B
| $625K | ﹤0.01% |
39,018
-828
| -2% | -$13.5K |
|
|
TPTX
2878
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $624K | ﹤0.01% |
16,608
| – | – |
|
2879
AstroNova
ALOT
$227M
| $619K | ﹤0.01% |
38,266
+15,860
| +71% | +$331K |
|
2880
Unity Bancorp
UNTY
$599M
| $612K | ﹤0.01% |
27,639
-1,381
| -5% | -$28.6K |
|
|
EIGR
2881
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $611K | ﹤0.01% |
1,989
-1,247
| -39% | -$405K |
|
|
LBC
2882
DELISTED
Luther Burbank Corporation Common Stock
LBC
| $604K | ﹤0.01% |
53,290
-4,208
| -7% | -$45.9K |
|
|
UBX
2883
DELISTED
Unity Biotechnology
UBX
| $601K | ﹤0.01% |
9,843
-482
| -5% | -$34.1K |
|
2884
First Northwest Bancorp
FNWB
$104M
| $598K | ﹤0.01% |
34,528
-1,568
| -4% | -$25.5K |
|
|
TTSH
2885
DELISTED
Tile Shop Holdings
TTSH
| $597K | ﹤0.01% |
187,017
-3,089
| -2% | -$9.44K |
|
2886
ADMA Biologics
ADMA
$2.22B
| $595K | ﹤0.01% |
133,787
+64,693
| +94% | +$270K |
|
2887
OptimizeRx
OPRX
$133M
| $595K | ﹤0.01% |
41,073
+9,865
| +32% | +$153K |
|
2888
Stagwell
STGW
$2.24B
| $591K | ﹤0.01% |
209,577
-12,665
| -6% | -$31.8K |
|
2889
Cue Biopharma
CUE
$114M
| $590K | ﹤0.01% |
2,332
+220
| +10% | +$52.8K |
|
|
OPTN
2890
DELISTED
OptiNose
OPTN
| $584K | ﹤0.01% |
5,560
-286
| -5% | -$28.5K |
|
2891
Ocular Therapeutix
OCUL
$2.02B
| $583K | ﹤0.01% |
191,831
+65,541
| +52% | +$293K |
|
|
TCFC
2892
DELISTED
The Community Financial Corporation Common Stock
TCFC
| $579K | ﹤0.01% |
17,302
+1,577
| +10% | +$50.7K |
|
|
CBIO
2893
Crescent Biopharma
CBIO
$626M
| $577K | ﹤0.01% |
1,340
-78
| -6% | -$50.2K |
|
2894
Bassett Furniture
BSET
$176M
| $575K | ﹤0.01% |
37,561
-1,263
| -3% | -$16.7K |
|
|
RLH
2895
DELISTED
Red Lions Hotel Corporation
RLH
| $573K | ﹤0.01% |
88,456
+18,430
| +26% | +$115K |
|
2896
Rafael Holdings
RFL
$107M
| $572K | ﹤0.01% |
27,637
-3,294
| -11% | -$67.2K |
|
|
GCAP
2897
DELISTED
Gain Capital Holdings, Inc.
GCAP
| $572K | ﹤0.01% |
108,264
-21,364
| -16% | -$99.9K |
|
|
FNHC
2898
DELISTED
FedNat Holding Company Common Stock
FNHC
| $569K | ﹤0.01% |
40,618
-2,701
| -6% | -$35.2K |
|
2899
LSB Industries
LXU
$693M
| $568K | ﹤0.01% |
142,467
-5,829
| -4% | -$20.8K |
|
2900
Weyco Group
WEYS
$440M
| $568K | ﹤0.01% |
25,116
+2,282
| +10% | +$56.9K |
|
Similar funds
VFT
Nuveen's Q3 2019 Portfolio in Review
As of Q3 2019, Nuveen held 3,301 positions worth $247B, down 2.7% from $254B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Nuveen withdrew a net $7.92B in Q3 2019, closing 86 positions and reducing 1,530 holdings. Its most notable exit was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $1.13B position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Nuveen opened a new position in Medallia, Inc. worth $97.7M.
- Nuveen's largest Q3 2019 buy was Medallia, Inc.: 3,562,327 shares worth $97.7M.
- Nuveen added most to Fidelity National Information Services in Q3 2019, an estimated $508M increase.
- Nuveen's biggest Q3 2019 reduction was Microsoft, cutting an estimated $408M.
- Nuveen fully exited iShares iBoxx $ Investment Grade Corporate Bond ETF in Q3 2019, selling an estimated $1.13B.
- Nuveen's ten largest holdings make up 18% of its $247B portfolio in Q3 2019.
- Nuveen opened 48 new positions and closed 86 in Q3 2019.
- Nuveen's portfolio value fell 2.7% quarter-over-quarter to $247B.
Based on Nuveen's 13F filing for Q3 2019, filed 14 Nov 2019.